aid: metagenomi
name: Metagenomi
description: >-
  Metagenomi Therapeutics, Inc. (Nasdaq: MGX) is an Emeryville, California clinical-stage
  genetic medicines company that mines metagenomics — DNA sequenced directly from
  environmental microbial communities — together with machine learning to discover novel
  gene-editing machinery from otherwise unknown organisms, then engineers it into in vivo
  genome-editing therapies. Its published toolbox spans five system classes: programmable
  CRISPR nucleases, ultra-small nucleases that package into a single AAV vector, base
  editors the company describes as "the smallest CRISPR base editors known", RNA Mediated
  Integration Systems (RIGS) for template-encoded edits, and CRISPR Associated Transposases
  (CASTs) for gene integrations exceeding 10,000 base pairs. The company completed its
  initial public offering on the Nasdaq Global Select Market in February 2024 at $15.00 per
  share and partners with Ionis Pharmaceuticals on gene-editing programs including ApoC-III,
  transthyretin (TTR) and angiotensinogen (AGT). Metagenomi sells therapeutics, not
  software: metagenomi.co is a seven-page Craft CMS marketing site with no developer
  program, no API, no SDK and no machine-readable specification of any kind. Its GitHub
  organization is real and first-party but publishes zero public repositories, and its only
  first-party software package — the `metagenomi` PyPI library of internal Docker helper
  scripts — has not shipped a release since July 2019.
url: https://raw.githubusercontent.com/api-evangelist/metagenomi/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
image: https://metagenomi.imgix.net/metagenomi-seo-image.png?auto=compress%2Cformat&crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=630&q=60&w=1200&s=dcdcd18b56fbe733f9ccf2ad0dd474dd
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline
specificationVersion: '0.23'
created: '2026-08-25'
modified: '2026-08-25'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Gene Editing
- CRISPR
- Genetic Medicine
- Genomics
- Drug Discovery
- Life Sciences
- Machine-Learning
- Metagenomics
- Research
tags_raw:
- Company
- Biotechnology
- Pharmaceuticals
- Gene Editing
- CRISPR
- Genetic Medicine
- Genomics
- Drug Discovery
- Life Sciences
- Machine Learning
- Metagenomics
- Research
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://metagenomi.co/
- type: InvestorRelations
  url: https://ir.metagenomi.co/
- type: Blog
  url: https://metagenomi.co/news
- type: Careers
  url: https://metagenomi.co/careers
- type: GitHubOrganization
  url: https://github.com/Metagenomi
- type: TermsOfService
  url: https://metagenomi.co/terms-of-use
- type: PrivacyPolicy
  url: https://metagenomi.co/privacy-policy
- type: SecondaryMarket
  url: https://forgeglobal.com/metagenomi_stock/
- type: Packages
  url: packages/metagenomi-packages.yml
- type: DomainSecurity
  url: security/metagenomi-domain-security.yml
- type: LLMsTxt
  url: llms/metagenomi-llms.txt
x-enrichment:
  date: '2026-08-25'
  status: minimal
  artifacts_added: 4
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Metagenomi (Nasdaq: MGX) is a clinical-stage in vivo genome-editing biotech whose product
    is a drug pipeline, not software — metagenomi.co is a seven-page Craft CMS marketing site
    whose own sitemap enumerates the entire property (about-us, research,
    novel-proprietary-systems, pipeline, terms-of-use, privacy-policy, careers) with no
    developer page of any kind, every spec and /.well-known/ path returns a real 404, and
    api./dev./developer./docs./app./platform.metagenomi.co do not resolve at all; the company's
    first-party GitHub organization is genuine but holds zero public repositories, and its only
    published package — `metagenomi` on PyPI, internal Docker helper scripts rather than an API
    client — last shipped a release on 2019-07-31.
  evidence:
  - url: https://metagenomi.co/
    status: 200
  - url: https://metagenomi.co/openapi.json
    status: 404
  - url: https://metagenomi.co/graphql
    status: 404
  - url: https://metagenomi.co/llms.txt
    status: 404
  - url: https://metagenomi.co/.well-known/agent-card.json
    status: 404
  - url: https://metagenomi.co/.well-known/security.txt
    status: 404
  - url: https://metagenomi.co/sitemaps-1-section-pages-1-sitemap.xml
    status: 200
  - url: https://ir.metagenomi.co/llms.txt
    status: 404
  - url: https://api.github.com/users/Metagenomi/repos
    status: 200
  - url: https://pypi.org/pypi/metagenomi/json
    status: 200
  checked: '2026-08-25'